Biolex Therapeutics.

PositionTriangle

PITTSBORO -- Biolex Therapeutics, which is developing treatments for hepatitis C, withdrew plans to go public because of unfavorable market conditions and because it had found financing elsewhere. Biolex never said how much...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT